Ordinary Adjustment | Solactive Eli Lilly Value Chain Index | Effective Date 7th November 2024
Solactive Eli Lilly Value Chain Index:
In the ordinary adjustment, the following composition will be implemented effective open 7th November 2024:
| SAMSUNG BIOLOGICS CO LTD |
| ELI LILLY & CO |
| THERMO FISHER SCIENTIFIC INC |
| LONZA GROUP AG |
| VEEVA SYSTEMS INC |
| CHUGAI PHARMACEUTICAL CO LTD ORD |
| ICON PLC |
| ILLUMINA INC |
| UNITED THERAPEUTICS CORP |
| CATALENT INC |
| INCYTE CORP |
| SHIONOGI & CO LTD ORD |
| HALOZYME THERAPEUTICS INC |
| TECAN GROUP AG-REG |
| BACHEM HOLDING AG-REG B |